This inventor holds 9 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Hansa Biopharma Ab, Hansa Medical Ab. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Introduction
Christian Kjellman, a prominent inventor based in Lund, Sweden, has made significant contributions to the field of therapeutic innovations. With an impressive portfolio of 8 patents, Kjellman's work focuses on enhancing the efficacy of therapies and therapeutic agents. His groundbreaking inventions have the potential to transform how diseases are treated and managed.
Latest Patents
Kjellman's latest patents include a novel method for improving the benefit of therapy to a subject. This method involves administering an agent that reduces Fc receptor binding of serum IgG molecules, followed by the application of a therapeutic agent. Furthermore, he has developed a method to mitigate the effects of pathogenic autoantibodies, comprising the administration of the same agent and possibly a treatment that removes endogenous autoantibodies. In addition, he has a patent for a new polypeptide that exhibits IgG cysteine protease activity, with applications in disease prevention and analysis relating to IgG.
Career Highlights
Throughout his career, Christian Kjellman has held positions at leading biotechnology companies such as Hansa Biopharma AB and Hansa Medical AB. His innovative approach and expertise have led to advancements in biopharmaceuticals, reflecting his unwavering commitment to improving patient outcomes through science and technology.
Collaborations
Kjellman's work has been enriched through collaborations with talented professionals, including Sofia Jarnum and Emma Nordahl. Their combined efforts have fostered a dynamic environment for research and development, driving forward-thinking solutions in the therapeutic landscape.
Conclusion
In summary, Christian Kjellman's contributions to the field of therapeutics exemplify the essence of innovation. With a robust track record of patents and collaborations, he continues to pave the way for advancements that hold the promise of better health solutions for patients worldwide. His work emphasizes the importance of research and development in the pursuit of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile